Table 2 Baseline characteristics per user group

Demographic

 Age, years, mean (SD)

48.3 (12.0)

52.1 (11.6)

55.3 (10.9)

0.001*

 Educational level, n (%)

0.95

  • Low

27 (9.2)

11 (8.3)

8 (9.2)

  • High

268 (90.8)

122 (91.7)

79 (90.8)

Medical history

 Parity 1 > child(ren), n (%)

245 (83.1)

117 (88.0)

74 (85.1)

0.42

 Postmenopausal, n (%)

0.001*

  • Yes

120 (40.7)

67 (50.4)

55 (63.2)

  • No

145 (49.2)

54 (40.6)

31 (35.6)

  • Unknown

30 (10.2)

12 (9.0)

1 (1.1)

 General quality of life (SF-12), mean (SD)

  • Physical health (PCS-12)

50.3 (7.6)

50.6 (7.7)

52.5 (5.8)

0.05

  • Mental health (MCS-12)

48.6 (9.4)

50.4 (8.0)

49.5 (8.6)

0.16

Incontinence related

 Incontinence type, n (%)

0.55

  • SUI

245 (83.1)

106 (79.7)

74 (85.1)

  • MUI

50 (16.9)

27 (20.3)

13 (14.9)

 Duration < 5 years, n (%)

164 (55.6)

78 (58.6)

51 (58.6)

0.79

 Severity (ICIQ-UI SF), mean (SD)

10.2 (3.2)

9.5 (3.2)

9.6 (2.9)

0.09

 Quality of life (ICIQ LUTS-QoL), mean (SD)

32.3 (7.1)

31.5 (7.0)

31.4 (5.8)

0.38

 Previous PFMT via therapist^a, n (%)

85 (29.1)

28 (21.2)

32 (36.8)

0.04*

 Previous contact with healthcare professional^a, n (%)

116 (40.1)

44 (33.3)

35 (40.7)

0.37

 Frequency of pelvic floor muscle exercises at baseline, n (%)

 < 0.001*

  • Never

157 (53.2)

49 (36.8)

25 (28.7)

  • < 1/week

112 (38.0)

63 (47.4)

43 (49.4)

  • > 1/week

26 (8.8)

21 (15.8)

19 (21.8)

 Expected ability to train pelvic floor muscles, mean (SD)

7.5 (1.4)

7.7 (1.4)

8.1 (1.5)

0.006*

 Expected treatment results^a, n (%)

0.09

  • Slight improvement

52 (17.7)

24 (18.0)

9 (10.3)

  • Major improvement

218 (74.1)

93 (69.9)

63 (72.4)

  • Cure

24 (8.2)

16 (12.0)

15 (17.2)